Skip to main content
. 2021 Sep;13(9):5439–5447. doi: 10.21037/jtd-21-920

Table 2. Patients’ outcomes.

Variable PROSM group (n=61) Control group (n=61) p value
ICU admission, n (%) 14 (23.0) 28 (45.9) 0.008a
Clinical complications, n (%) 5 (8.2) 6 (9.8) 0.752a
Surgical complications, n (%) 4 (6.6) 9 (14.8) 0.142a
Reoperation, n (%) 3 (4.9) 1 (1.6) 0.619b
Mortality, n (%) 0 (0.0) 1 (1.6) 1.000b
ICU LOS, days
   Median (IQR) 0.0 (0.00) 0.0 (2.00) 0.001c
   Mean (SD) 0.3 (0.58) 1.2 (1.65)
Hospital LOS, days
   Median (IQR) 1.0 (1.00) 3.0 (3.00) <0.001c
   Mean (SD) 1.6 (1.32) 3.9 (3.25)
Chest drain duration, days <0.001c
   Median (IQR) 1.0 (1.00) 3.0 (3.00)
Matmed costs, R$ 2,458.26 2,052.35 0.933c
   Median (IQR) (3,536.30) (4,319.70)
Procedure costs, R$ 2,726.47 4,311.41 <0.001c
   Median (IQR) (1,709.58) (2,205.63)
Daily costs, R$ 2,627.78 4,848.36 <0.001c
   Median (IQR) (1,780.15) (4,327.82)
Total costs, R$ 8,119.15 10,998.36 <0.001c
   Median (IQR) (5,577.93) (9,763.48)
Post-surgical costs, R$ 4,068.92 6,626.96 <0.001c
   Median (IQR) (4,068.92) (6,626.96)

a, Chi-Square test; b, Fisher’s exact test; c, Mann-Whitney-U test. PROSM, Santa Marcelina’s Enhanced Protocol; ICU, Intensive Care Unit; LOS, length of stay; MatMed, materials and medication.